File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease

TitleSerial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease
Authors
KeywordsCarcinoma
Chronic disease
Hepatocellular
Liver diseases
Magnetic resonance imaging
Issue Date2009
Citation
Journal of the Medical Association of Thailand, 2009, v. 92, n. 4, p. 548-555 How to Cite?
AbstractObjective: To determine the significance of small arterially-enhancing liver lesions seen with magnetic resonance imaging (MRI) in patients with chronic liver disease. Material and Method: Our institutional review board approved this retrospective study, without requiring informed consent. Over a two-year period, 258 consecutive patients with cirrhosis or chronic hepatitis underwent multiphase three-dimensional, gadolinium-enhanced, breath-hold gradient-echo MRI. From this group, 29 patients underwent at least one follow-up MR study. When a small (≤ 20 mm) arterially-enhancing lesion was detected, the maximum diameter, shape, signal intensities (T1-weighted and T2-weighted), and pattern of enhancement were evaluated to assess the associations between the imaging appearance on initial MR exam and subsequent behavior on follow-up imaging. Statistical testing was performed with JMP Statistical Software (SAS, Inc., Cary, NC) and StatXact 7 Statistical Software for Exact Nonparmetric Inference (Cytel, Inc. Cambride, MA). Results: Sixty-five small (≤ 20 mm) arterially-enhancing lesions were detected in 29 patients. Ten of 65 lesions (15%) in nine patients were subsequently proven to represent hepatocellular carcinoma (HCC), while the remaining lesions either disappeared (46) or remained stable in size (9). Of the 10 lesions subsequently proven to represent HCC, eight lesions converted from hypo- or isointense to hyperintense on subsequent T2-weighted MRI (p < 0.001), seven lesions converted from hyper- or isointense to hypointense on subsequent T1-weighted images (p < 0.001), seven lesions demonstrated growth on subsequent MRI exam (mean increase in mean diameter = 1.4 cm), and five lesions subsequently developed rim enhancement that was not initially present. Conclusion: Small, arterially-enhancing lesions detected with MRI have a low likelihood of representing HCC, and MRI follow-up of such lesions is a reasonable approach. Lesions that increase in size, convert to hypointense on subsequent T1W images, convert to hyperintense in T2W images, or develop rim enhancement on follow-up MRI images are concerning and should prompt consideration of intervention.
Persistent Identifierhttp://hdl.handle.net/10722/316019
ISSN
2023 SCImago Journal Rankings: 0.135

 

DC FieldValueLanguage
dc.contributor.authorKorpraphong, Pornpim-
dc.contributor.authorLeyendecker, John R.-
dc.contributor.authorHildebolt, Charles F.-
dc.contributor.authorNarra, Vamsri-
dc.contributor.authorBae, Klongtae Ty-
dc.contributor.authorBrown, Jeffrey J.-
dc.date.accessioned2022-08-24T15:48:58Z-
dc.date.available2022-08-24T15:48:58Z-
dc.date.issued2009-
dc.identifier.citationJournal of the Medical Association of Thailand, 2009, v. 92, n. 4, p. 548-555-
dc.identifier.issn0125-2208-
dc.identifier.urihttp://hdl.handle.net/10722/316019-
dc.description.abstractObjective: To determine the significance of small arterially-enhancing liver lesions seen with magnetic resonance imaging (MRI) in patients with chronic liver disease. Material and Method: Our institutional review board approved this retrospective study, without requiring informed consent. Over a two-year period, 258 consecutive patients with cirrhosis or chronic hepatitis underwent multiphase three-dimensional, gadolinium-enhanced, breath-hold gradient-echo MRI. From this group, 29 patients underwent at least one follow-up MR study. When a small (≤ 20 mm) arterially-enhancing lesion was detected, the maximum diameter, shape, signal intensities (T1-weighted and T2-weighted), and pattern of enhancement were evaluated to assess the associations between the imaging appearance on initial MR exam and subsequent behavior on follow-up imaging. Statistical testing was performed with JMP Statistical Software (SAS, Inc., Cary, NC) and StatXact 7 Statistical Software for Exact Nonparmetric Inference (Cytel, Inc. Cambride, MA). Results: Sixty-five small (≤ 20 mm) arterially-enhancing lesions were detected in 29 patients. Ten of 65 lesions (15%) in nine patients were subsequently proven to represent hepatocellular carcinoma (HCC), while the remaining lesions either disappeared (46) or remained stable in size (9). Of the 10 lesions subsequently proven to represent HCC, eight lesions converted from hypo- or isointense to hyperintense on subsequent T2-weighted MRI (p < 0.001), seven lesions converted from hyper- or isointense to hypointense on subsequent T1-weighted images (p < 0.001), seven lesions demonstrated growth on subsequent MRI exam (mean increase in mean diameter = 1.4 cm), and five lesions subsequently developed rim enhancement that was not initially present. Conclusion: Small, arterially-enhancing lesions detected with MRI have a low likelihood of representing HCC, and MRI follow-up of such lesions is a reasonable approach. Lesions that increase in size, convert to hypointense on subsequent T1W images, convert to hyperintense in T2W images, or develop rim enhancement on follow-up MRI images are concerning and should prompt consideration of intervention.-
dc.languageeng-
dc.relation.ispartofJournal of the Medical Association of Thailand-
dc.subjectCarcinoma-
dc.subjectChronic disease-
dc.subjectHepatocellular-
dc.subjectLiver diseases-
dc.subjectMagnetic resonance imaging-
dc.titleSerial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.pmid19374308-
dc.identifier.scopuseid_2-s2.0-65649153745-
dc.identifier.volume92-
dc.identifier.issue4-
dc.identifier.spage548-
dc.identifier.epage555-
dc.identifier.eissn0125-2208-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats